In seminal studies, Perlman’s group demonstrated that both CD4+ and CD8+ T-cell immunities were necessary and sufficient to block the infection in mice by a mouse-adapted SARS-CoV strain in the absence of antibody response [29]. The gene discussed is CD8A; the disease is infection.